Company Overview - Shanghai Yuanbao Medical Equipment Co., Ltd. was established in 2022 and is headquartered in Shanghai [2][3] - The company focuses on the intersection of brain science and intelligent medical technology, engaging in the development of neuro-regulation devices, brain-machine interface technologies, and neuro-rehabilitation solutions [4] Financing Information - On March 23, 2026, the company announced the completion of its angel round financing, raising several tens of millions of RMB, with exclusive strategic investment from the Shanghai Science and Technology Innovation Investment Group's intellectual property fund [2][7] Product and Technology Introduction - The company is currently focusing on neuro-regulation and brain-machine interface products and technologies, including: - Intelligent precise neuro-circuit multi-target regulation robotic system for neuro-regulation treatment scenarios, supporting multi-modal imaging positioning and robotic arm-assisted operations, applicable in clinical neuro-rehabilitation [5] - MRI target calculation AI system for processing brain imaging data and identifying personalized neuro-regulation targets [5] - Multi-modal neuro-circuit decoding technology that combines fMRI, DTI, and EEG data for neuro-circuit analysis and localization [5] - Non-invasive neuro-regulation technology applicable in rehabilitation scenarios for neurological disorders such as post-stroke functional impairment and cognitive disorders [5] Research and Development Focus - The company is engaged in the iterative development of the intelligent precise neuro-circuit multi-target regulation robotic system, MRI target calculation AI system, clinical registration applications, market expansion, and cutting-edge technology research [6] Patent Information - The company has several patents related to its technologies, including: - A stroke rehabilitation system based on cortical hippocampal network neuro-oscillation regulation [8] - A cognitive training system and method [8] - A method for individualized localization of neuro-circuits based on multi-modal brain imaging, which has been authorized [8]
数千万元融资!神经调控公司完成天使轮
思宇MedTech·2026-03-25 08:33